Federal Support for Domestic Pharmaceutical Ingredient Manufacturing.
This act expands federal support for bioindustrial manufacturing processes to include active pharmaceutical ingredients. This means the U.S. government will back domestic production of essential drug components, potentially increasing drug availability and reducing reliance on foreign supplies. Citizens may experience greater security in accessing necessary medications as a result.
Key points
Extends government support to include the manufacturing of active pharmaceutical ingredients in the U.S.
Aims to enhance the security of drug supplies by fostering domestic production.
Potentially reduces reliance on imported pharmaceutical substances.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.